SEC Form 4 · accession 0001225208-15-005611
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher G Ryan
Officer — President, PPS, Americas
Period of report
Feb 17, 2015
Accepted (ET)
Feb 25, 2015 · 11:33 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $51.53 | Feb 17, 2015 | A | 10,244 | A | Feb 17, 2015 | Feb 17, 2025 | Common Stock | 10,244 | 10,244 | D |
| Stock Option (Right to Buy)F2 | $51.53 | Feb 17, 2015 | A | 5,120 | A | Feb 17, 2015 | Feb 17, 2025 | Common Stock | 5,120 | 15,364 | D |
Explanation of responses
- F1Stock Option term is 10 years. 2,561 options or 25% vested on 02/17/15, 25% will vest on 02/17/2016, 25% will vest on 2/17/2017, and 25% will vest on 2/17/2017.
- F2Stock Option term is 10 years. 2,560 options or 50% vested on 02/17/15. 25% will vest on 02/17/2016 and 25% will vest on 2/17/2017.